Release and metabolism of ATP and β-NAD. (a–d) Original chromatograms for tissue superfusate samples collected before [prestimulation (PS)] or during EFS (16 Hz, 0.5 ms, 15 V, 480 pulses) in the absence or presence of neural blockers. Scale applies to all chromatograms. LU, luminescence units. (a) A sample collected PS contained small amounts of ATP, ADP, AMP, and adenosine (ADO). (b) EFS (16 Hz) evoked overflow of ATP, ADP, AMP, ADO, and a mixture of β-NAD, cADPR, and ADPR. (c) TTX (0.3 μM; 30-min perfusion) reduced the overflow of all purines evoked by EFS at 16 Hz. (d) The 16-Hz EFS-evoked overflow of purine nucleotides and ADO was reduced by 50 nM ω-conotoxin GVIA (ω-Ctx; 30-min perfusion). (e–j) Averaged data. Overflow (femtomoles per milligram of tissue) is the overflow during EFS less overflow before EFS (ST-PS) (n = 4–6 per group). Data are presented as means ± SEM. (e–g) The evoked overflow of ATP, ADP, and AMP did not increase with stimulation frequency (4 and 16 Hz; P > 0.05). The evoked overflow of ATP was not affected by TTX (P = 0.2594) or ω-Ctx (P = 0.2247). Likewise, the overflow of ADP was not reduced by TTX (P = 0.1358) or ω-Ctx (P = 0.5618). The overflow of AMP also was not changed by either TTX (P = 0.2928) or ω-Ctx (P = 0.3820). (h–j) The evoked overflow of β-NAD/cADPR/ADPR, and ADO, as well as of total purines, increased with stimulation frequency (P = 0.0437, 0.0429, and <0.0001 for β-NAD/cADPR/ADPR, ADO, and total purines, respectively) and was reduced by both TTX (P = 0.0372, 0.0001, and <0.0001 for β-NAD/cADPR/ADPR, ADO, and total purines, respectively) and ω-CtxGVIA (P = 0.0492, 0.0027, and <0.0001 for β-NAD/cADPR/ADPR, ADO, and total purines, respectively). Asterisks denote significant differences from 16-Hz controls (P < 0.05). Open circles denote significant differences from 4-Hz controls (P < 0.05). (k–m) Original chromatograms of the 7.2-min (cADPR-containing) fraction (k), the 8.5-min (ADPR-containing) fraction (l), and the 10.5-min (β-NAD-containing) fraction (m) of tissue superfusate samples (30 chambers combined) collected during EFS at 16 Hz, 0.5 ms, for 30 s and ethenoderivatized with 2-chloroacetaldehyde at 80°C (pH 4.0) for 40 min. Note that the 7.2-min fraction also contained ATP. (n) Highest amounts of 1,N6-etheno-ADPR (eADPR) were observed in the 10.5-min (β-NAD-containing) fraction. The amount of β-NAD exceeded the amount of ATP by at least 30-fold. (o) Quantitative PCR data for expression of Kit in whole-muscle homogenates (filled bar) and sorted ICCs (open bar). The relative amount of Kit expression is enriched in ICCs (P < 0.001). (p) Quantitative PCR data for expression of CD38 in whole-muscle homogenates (filled bar) and ICCs (open bar). The relative amount of CD38 expression is enriched in ICCs (P < 0.001). Data in o and p are means ± SEM from three experiments.